These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 17374734)
1. Genetic and epigenetic regulation of the human prostacyclin synthase promoter in lung cancer cell lines. Stearman RS; Grady MC; Nana-Sinkam P; Varella-Garcia M; Geraci MW Mol Cancer Res; 2007 Mar; 5(3):295-308. PubMed ID: 17374734 [TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the promoter region of prostacyclin synthase gene in chronic thromboembolic pulmonary hypertension. Amano S; Tatsumi K; Tanabe N; Kasahara Y; Kurosu K; Takiguchi Y; Kasuya Y; Kimura S; Kuriyama T Respirology; 2004 Jun; 9(2):184-9. PubMed ID: 15182267 [TBL] [Abstract][Full Text] [Related]
4. Prostacyclin synthase and arachidonate 5-lipoxygenase polymorphisms and risk of colorectal polyps. Poole EM; Bigler J; Whitton J; Sibert JG; Potter JD; Ulrich CM Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):502-8. PubMed ID: 16537708 [TBL] [Abstract][Full Text] [Related]
5. Hypermethylation of the prostacyclin synthase (PTGIS) promoter is a frequent event in colorectal cancer and associated with aneuploidy. Frigola J; Muñoz M; Clark SJ; Moreno V; Capellà G; Peinado MA Oncogene; 2005 Nov; 24(49):7320-6. PubMed ID: 16007128 [TBL] [Abstract][Full Text] [Related]
6. Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Yanada M; Yaoi T; Shimada J; Sakakura C; Nishimura M; Ito K; Terauchi K; Nishiyama K; Itoh K; Fushiki S Oncol Rep; 2005 Oct; 14(4):817-22. PubMed ID: 16142337 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of cell adhesion molecule 1 in different cancer progenitor cells of transgenic c-Myc and c-Raf mouse lung tumors. Reamon-Buettner SM; Borlak J Cancer Res; 2008 Sep; 68(18):7587-96. PubMed ID: 18794147 [TBL] [Abstract][Full Text] [Related]
8. Decreased expression of KAI1/CD82 metastasis suppressor gene is associated with loss of heterozygosity in melanoma cell lines. Kim YI; Shin MK; Lee JW; Chung JH; Lee MH Oncol Rep; 2009 Jan; 21(1):159-64. PubMed ID: 19082457 [TBL] [Abstract][Full Text] [Related]
9. Imprinted tumor suppressor genes ARHI and PEG3 are the most frequently down-regulated in human ovarian cancers by loss of heterozygosity and promoter methylation. Feng W; Marquez RT; Lu Z; Liu J; Lu KH; Issa JP; Fishman DM; Yu Y; Bast RC Cancer; 2008 Apr; 112(7):1489-502. PubMed ID: 18286529 [TBL] [Abstract][Full Text] [Related]
10. Down-regulation of MTUS1 in human colon tumors. Zuern C; Heimrich J; Kaufmann R; Richter KK; Settmacher U; Wanner C; Galle J; Seibold S Oncol Rep; 2010 Jan; 23(1):183-9. PubMed ID: 19956880 [TBL] [Abstract][Full Text] [Related]
11. Functional polymorphism of the promoter region of the prostacyclin synthase gene and severity of RSV infection in hospitalized children. Hashimoto K; Ishibashi K; Gebretsadik T; Hartert TV; Yamamoto A; Nakayama T; Ohashi K; Sakata H; Kawasaki Y; Katayose M; Sakuma H; Suzuki H; Hosoya M; Peebles RS; Suzutani T J Med Virol; 2008 Nov; 80(11):2015-22. PubMed ID: 18814254 [TBL] [Abstract][Full Text] [Related]
12. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis. Vuillemenot BR; Pulling LC; Palmisano WA; Hutt JA; Belinsky SA Carcinogenesis; 2004 Apr; 25(4):623-9. PubMed ID: 14656941 [TBL] [Abstract][Full Text] [Related]
13. Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q23-25. Tessema M; Willink R; Do K; Yu YY; Yu W; Machida EO; Brock M; Van Neste L; Stidley CA; Baylin SB; Belinsky SA Cancer Res; 2008 Mar; 68(6):1707-14. PubMed ID: 18339850 [TBL] [Abstract][Full Text] [Related]
14. Silencing of DUOX NADPH oxidases by promoter hypermethylation in lung cancer. Luxen S; Belinsky SA; Knaus UG Cancer Res; 2008 Feb; 68(4):1037-45. PubMed ID: 18281478 [TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the SFRP2 gene is a high-frequent alteration and tumor-specific epigenetic marker in human breast cancer. Veeck J; Noetzel E; Bektas N; Jost E; Hartmann A; Knüchel R; Dahl E Mol Cancer; 2008 Nov; 7():83. PubMed ID: 18990230 [TBL] [Abstract][Full Text] [Related]
17. Homo sapiens lactate dehydrogenase c (Ldhc) gene expression in cancer cells is regulated by transcription factor Sp1, CREB, and CpG island methylation. Tang H; Goldberg E J Androl; 2009; 30(2):157-67. PubMed ID: 18930904 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of the metastasis suppressor RECK enhances invasion of human colon cancer cells. Cho CY; Wang JH; Chang HC; Chang CK; Hung WC J Cell Physiol; 2007 Oct; 213(1):65-9. PubMed ID: 17443689 [TBL] [Abstract][Full Text] [Related]
19. Wnt signalling in human breast cancer: expression of the putative Wnt inhibitor Dickkopf-3 (DKK3) is frequently suppressed by promoter hypermethylation in mammary tumours. Veeck J; Bektas N; Hartmann A; Kristiansen G; Heindrichs U; Knüchel R; Dahl E Breast Cancer Res; 2008; 10(5):R82. PubMed ID: 18826564 [TBL] [Abstract][Full Text] [Related]
20. Cyclic strain is a weak inducer of prostacyclin synthase expression in bovine aortic endothelial cells. Segurola RJ; Oluwole B; Mills I; Yokoyama C; Tanabe T; Kito H; Nakajima N; Sumpio BE J Surg Res; 1997 Apr; 69(1):135-8. PubMed ID: 9202659 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]